Relay Therapeutics
(NASDAQ:RLAY)
16.47
-0.18[-1.08%]
At close: May 25
16.47
00
After Hours: 4:01PM EDT
Day High/Low15.97 - 16.97
52 Week High/Low14.37 - 38.6
Open / Close16.58 / 16.47
Float / Outstanding61.8M / 108.7M
Vol / Avg.424.3K / 745.9K
Mkt Cap1.8B
P/E-
50d Avg. Price25.65
Div / Yield-
Payout Ratio-
EPS-0.57
Total Float61.8M

Relay Therapeutics (NASDAQ:RLAY), Quotes and News Summary

Relay Therapeutics (NASDAQ: RLAY)

Day High/Low15.97 - 16.97
52 Week High/Low14.37 - 38.6
Open / Close16.58 / 16.47
Float / Outstanding61.8M / 108.7M
Vol / Avg.424.3K / 745.9K
Mkt Cap1.8B
P/E-
50d Avg. Price25.65
Div / Yield-
Payout Ratio-
EPS-0.57
Total Float61.8M
load more
Sector: Health Care.Industry: Biotechnology
Relay Therapeutics Inc is a clinical-stage, precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is advancing its pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008 and RLY-1971, as well as its PI3Ka mutant selective program, known as the RLY-PI3K1047 program. Its initiated a Phase 1 clinical trial for RLY-1971 in patients with advanced solid tumors in the first quarter of 2020 and a first-in-human clinical trial of RLY-4008 enriched for patients with advanced solid tumors having oncogenic FGFR2 alterations in the third quarter of 2020.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.620-0.570 0.0500
REV170.000K419.000K249.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Relay Therapeutics Questions & Answers

Q
How do I buy Relay Therapeutics (RLAY) stock?
A

You can purchase shares of Relay Therapeutics (NASDAQ: RLAY) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Relay Therapeutics's (RLAY) competitors?
Q
What is the target price for Relay Therapeutics (RLAY) stock?
A

The latest price target for Relay Therapeutics (NASDAQ: RLAY) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 42.00 expecting RLAY to rise to within 12 months (a possible 155.01% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Relay Therapeutics (RLAY)?
A

The stock price for Relay Therapeutics (NASDAQ: RLAY) is $16.47 last updated May 25, 2022, 8:00 PM UTC.

Q
Does Relay Therapeutics (RLAY) pay a dividend?
A

There are no upcoming dividends for Relay Therapeutics.

Q
When is Relay Therapeutics (NASDAQ:RLAY) reporting earnings?
A

Relay Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Relay Therapeutics (RLAY) going to split?
A

There is no upcoming split for Relay Therapeutics.

Q
What sector and industry does Relay Therapeutics (RLAY) operate in?
A

Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.